These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35746458)

  • 1. Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia.
    Day D; Grech L; Nguyen M; Bain N; Kwok A; Harris S; Chau H; Chan B; Blennerhassett R; Nott L; Hamad N; Tognela A; Hoffman D; McCartney A; Webber K; Wong J; Underhill C; Sillars B; Winkel A; Savage M; Loe BS; Freeman D; Segelov E; On Behalf Of The Canvaccs Diabvaccs And Msvaccs Investigators
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers.
    Bain N; Nguyen M; Grech L; Day D; McCartney A; Webber K; Kwok A; Harris S; Chau H; Chan B; Nott L; Hamad N; Tognela A; Underhill C; Loe BS; Freeman D; Segelov E; On Behalf Of The Canvaccs Investigators
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis.
    Grech L; Kwok A; Nguyen M; Winkel A; Butler E; Allan M; Bain N; Segelov E; On Behalf Of The Msvaccs Investigators
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and Concerns.
    Grech L; Loe BS; Day D; Freeman D; Kwok A; Nguyen M; Bain N; Segelov E
    Behav Med; 2023; 49(4):402-411. PubMed ID: 35703037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes towards COVID-19 vaccination in adults with haematological malignancies.
    Blennerhassett R; Hamad N; Grech L; Kwok A; Choi T; Forsyth C; Jagger J; Opat S; Harris S; Chan BA; Nguyen M; Bain N; Day D; Segelov E;
    Acta Haematol; 2024 Jan; ():. PubMed ID: 38290477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia.
    Wang H; Grech L; Wong J; Hoffman D; de Courten B; Sillars B; Savage M; Kwok A; Nguyen M; Bain N; Day D; Segelov E; On Behalf Of The Diabvaccs Investigators
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932391
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study.
    Nguyen M; Bain N; Grech L; Choi T; Harris S; Chau H; Freeman D; Kwok A; Williams J; McCartney A; Webber K; Day D; Segelov E
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):570-577. PubMed ID: 35043559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model.
    Choi T; Chan B; Grech L; Kwok A; Webber K; Wong J; Nguyen M; Bain N; Day D; McCartney A; Hamer R; Segelov E; On Behalf Of The Canvaccs Diabvaccs And Msvaccs Investigators
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851117
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 Vaccine-Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis.
    Benham JL; Atabati O; Oxoby RJ; Mourali M; Shaffer B; Sheikh H; Boucher JC; Constantinescu C; Parsons Leigh J; Ivers NM; Ratzan SC; Fullerton MM; Tang T; Manns BJ; Marshall DA; Hu J; Lang R
    JMIR Public Health Surveill; 2021 Dec; 7(12):e30424. PubMed ID: 34779784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mediating Roles of Medical Mistrust, Knowledge, Confidence and Complacency of Vaccines in the Pathways from Conspiracy Beliefs to Vaccine Hesitancy.
    Zhang X; Guo Y; Zhou Q; Tan Z; Cao J
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.
    Marzo RR; Ahmad A; Islam MS; Essar MY; Heidler P; King I; Thiyagarajan A; Jermsittiparsert K; Songwathana K; Younus DA; El-Abasiri RA; Bicer BK; Pham NT; Respati T; Fitriyana S; Faller EM; Baldonado AM; Billah MA; Aung Y; Hassan SM; Asad MM; El-Fass KA; Bhattacharya S; Shrestha S; Hamza NAE; Friedmann P; Head M; Lin Y; Yi S
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010103. PubMed ID: 35089917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Parental Attitudes Toward COVID-19 Vaccination and Routine Childhood Vaccination During the COVID-19 Pandemic: Repeated Cross-sectional Survey Study.
    Wang Q; Xiu S; Yang L; Han Y; Cui T; Shi N; Liu M; Yi Y; Liu C; Wang X; Yang G; Ji L; Zhou W; Jin H; Zhen S; Lin L
    JMIR Public Health Surveill; 2022 May; 8(5):e33235. PubMed ID: 35486516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qatar Healthcare Workers' COVID-19 Vaccine Hesitancy and Attitudes: A National Cross-Sectional Survey.
    Kumar R; Alabdulla M; Elhassan NM; Reagu SM
    Front Public Health; 2021; 9():727748. PubMed ID: 34513792
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale.
    Kotta I; Kalcza-Janosi K; Szabo K; Marschalko EE
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-10. PubMed ID: 34919494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of COVID-19 Vaccine Hesitancy Among the Black Asian Ethnic Minority in New South Wales, Australia.
    Zengeni M; Briggs NN
    Cureus; 2023 Jun; 15(6):e40626. PubMed ID: 37350977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Provision and Vaccine Hesitancy at a Central Hospital COVID-19 Vaccination Site in South Africa after Four Waves of the Pandemic.
    Nair S; Tshabalala K; Slingers N; Vanleeuw L; Basu D; Abdullah F
    Diseases; 2024 May; 12(6):. PubMed ID: 38920545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China.
    Akel KB; Masters NB; Shih SF; Lu Y; Wagner AL
    Hum Vaccin Immunother; 2021 Aug; 17(8):2639-2646. PubMed ID: 33769209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: A cross-sectional study.
    Kiefer MK; Mehl R; Costantine MM; Johnson A; Cohen J; Summerfield TL; Landon MB; Rood KM; Venkatesh KK
    BJOG; 2022 Jul; 129(8):1342-1351. PubMed ID: 35104382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.